This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Postoperative Nausea and Vomiting
and you are a woman who is
between 18 and 40
years old
Phase
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

Patients who present for scheduled (non-emergent) cesarean section will be given either intravenous dexamethasone or placebo prior to receiving a duramorph containing spinal anesthetic. The investigators will then compare the incidence of nausea and vomiting and the use of rescue anti-nausea medications in both groups. Our hypothesis is that patients receiving dexamethasone prior to duramorph containing spinal anesthesia for cesarean section will have a significantly lower incidence and severity of PONV at 0, 1, 3, 6, and 24 hours following surgery.

Provided treatments

  • Drug: Dexamethasone
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT01734161. The sponsor of the trial is Weill Medical College of Cornell University and it is looking for 122 volunteers for the current phase.
Official trial title:
A Prospective, Randomized, Double-Blinded Study to Evaluate the Efficacy of Intravenous Dexamethasone for Nausea Prophylaxis Prior to Duramorph and Bupivacaine Spinal Anesthesia for Scheduled Cesarean Section